N-methyl-3-methyl-2-butenamide | 1189-04-4

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: N-methyl-3-methyl-2-butenamide
• 英文别名: N-methylsenecioamide；N-methyl-3,3-dimethylacrylamide；N-Methylsenecioamid；4-Methyl-but-2-ensaeure-methylamid；N-Methyl-β-methyl-crotonamid；3-methyl-crotonic acid methylamide；3-Methyl-crotonsaeure-methylamid；3,N-Dimethyl-crotonamid；N,3-dimethylbut-2-enamide
• CAS: 1189-04-4
• 化学式: C₆H₁₁NO
• mdl: MFCD19159619
• 分子量: 113.159
• InChiKey: HJHZTGFGWDGQQS-UHFFFAOYSA-N

物化性质

• 熔点：
  77-78 °C
• 沸点：
  170-172 °C(Press: 12 Torr)
• 密度：
  0.915 g/cm3(Temp: 25 °C)

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  8
• 可旋转键数：
  1
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  N-methyl-3-methyl-2-butenamide 在 对甲苯磺酸 作用下， 以 环己烷 为溶剂， 反应 12.25h， 生成 5-methyl-1-methylamino-2-phenyl-1,4-hexadien-3-one
  参考文献：
  名称：

  Synthesis of amides from Glycosmis species: Methylthiopropenoic acid, methylsulfonylpropenoic acid, thiocarbamic acid S-methyl ester, and senecioic acid amides

  摘要：

  Representative samples of several types of naturally occurring amides from south and southeast Asian Glycosmis species were synthesized for proof of structures and for bioactivity testing. With one exception (senecioic acid) all these amides were characterized by sulfur containing acid components (methylthiopropenoic acid methylsulfonylpropenoic acid and thiocarbamic acid) in combination with phenethylamine derived amino moieties. (C) 1997 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0040-4020(97)10297-6
• 作为产物：
  描述：

  dimethyl N-(3-methylbut-2-enoyl)-N-methylphosphoramidothionate 在 水 作用下， 以 四氢呋喃 、 四氯化碳 为溶剂， 生成 N-methyl-3-methyl-2-butenamide
  参考文献：
  名称：

  A new route to N-monosubstituted thioamides utilizing phosphoramidothionates as reagents for the thioamidation of carboxylic acids

  摘要：

  DOI：

  10.1021/jo00312a012

文献信息

• [EN] CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS<br/>[FR] ENTITÉS CHIMIQUES, COMPOSITIONS ET MÉTHODES PARTICULIÈRES
  申请人：NEUPHARMA INC

  公开号：WO2018035061A1

  公开（公告）日：2018-02-22

  Chemical entities that are kinase inhibitors, pharmaceutical compositions and methods of treatment of cancer are described.

  化学实体、药物组合物及其用于治疗癌症的方法，所述化学实体为激酶抑制剂。
• SUBSTITUTED CYANO CYCLOALKYL PENTA-2,4-DIENES, CYANO CYCLOALKYL PENT-2-EN-4-YNES, CYANO HETEROCYCLYL PENTA-2,4-DIENES AND CYANO HETEROCYCLYL PENT-2-EN-4-YNES AS ACTIVE SUBSTANCES
  申请人：BAYER CROPSCIENCE AKTIENGESELLSCHAFT

  公开号：US20170210701A1

  公开（公告）日：2017-07-27

  The invention relates to cyano cycloalkyl penta-2,4-dienes, cyano cycloalkyl pent-2-en-4-ynes, cyano heterocyclyl penta-2,4-dienes and cyano heterocyclyl pent-2-en-4-ynes of general formula (I), or the salts thereof, where [X-Y], Q, R 1 , R 2 , A 1 , A 2 , V, W, m and n have the definitions specified in the description. The invention also relates to a production method for same and to the use of same for increasing stress tolerance in plants against abiotic stress, and/or for increasing the plant yield.

  该发明涉及一般式(I)的氰基环烷基戊二烯、氰基环烷基戊-2-炔、氰基杂环烷基戊二烯和氰基杂环烷基戊-2-炔，或其盐，其中[X-Y]、Q、R1、R2、A1、A2、V、W、m和n的定义如描述中所指定。该发明还涉及同类物质的生产方法以及将其用于增加植物对非生物胁迫的抗逆性和/或增加植物产量。
• [EN] PYRAZOLE COMPOUNDS AS MODULATORS OF FSHR AND USES THEREOF<br/>[FR] COMPOSÉS DE PYRAZOLE UTILISÉS EN TANT QUE MODULATEURS DE FSHR ET LEURS UTILISATIONS
  申请人：TOCOPHERX INC

  公开号：WO2015196759A1

  公开（公告）日：2015-12-30

  Disclosed are pyrazole compounds, and pharmaceuticaly acceptable compositions thereof. The compounds and the compositions can be used for positive allosteric modulators of follicle stimulating hormone receptor (FSHR).

  揭示了吡唑化合物及其药用组合物。这些化合物和组合物可用作促卵泡激素受体（FSHR）的阳性变构调节剂。
• SUBSTITUTED 5-(BICYCLO[4.1.0]HEPT-3-EN-2-YL)PENTA-2,4-DIENES AND 5-(BICYCLO[4.1.0]HEPT-3-EN-2-YL)PENT-2-ENE-4-INES AS ACTIVE AGENTS AGAINST ABIOTIC STRESSES IN PLANTS
  申请人：Frackenpohl Jens

  公开号：US20140051577A1

  公开（公告）日：2014-02-20

  The invention relates to substituted 5-(bicyclo[4.1.0]hept-3-en-2-yl)penta-2,4-dienes and 5-(bicyclo[4.1.0]hept-3-en-2-yl)pent-2-ene-4-ines of the formula (I) and salts thereof, where the radicals R1, R2, R3, R4, R5, [X—Y] and Q are each as defined in the description, to processes for preparation thereof and to the use thereof for enhancing stress tolerance in plants with respect to abiotic stress, and/or for increasing plant yield.

  该发明涉及代换的5-(bicyclo[4.1.0]庚-3-烯-2-基)戊-2,4-二烯和5-(bicyclo[4.1.0]庚-3-烯-2-基)戊-2-烯-4-炔的化合物及其盐，其中基团R1、R2、R3、R4、R5、[X—Y]和Q的定义如描述中所示，以及其制备方法和用途，用于增强植物对非生物胁迫的抗压能力，和/或增加植物产量。
• [EN] POLYCYCLIC INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7)<br/>[FR] INHIBITEURS POLYCYCLIQUES DE KINASE CYCLINE-DÉPENDANTE 7 (CDK7)
  申请人：DANA FARBER CANCER INST INC

  公开号：WO2015058140A1

  公开（公告）日：2015-04-23

  The present invention provides novel compounds of Formula (I), and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, prodrugs, and compositions thereof. Also provided are methods and kits involving the inventive compounds or compositions for treating or preventing proliferative diseases (e.g., cancers (e.g., leukemia, lymphoma, melanoma, multiple myeloma, breast cancer, Ewing' s sarcoma, osteosarcoma, brain cancer, neuroblastoma, lung cancer), benign neoplasms, angiogenesis, inflammatory diseases, autoinflammatory diseases, and autoimmune diseases) in a subject. Treatment of a subject with a proliferative disease using a compound or composition of the invention may inhibit the aberrant activity of a kinase, such as a cyclin-dependent kinase (CDK) (e.g., cyclin-dependent kinase 7 (CDK7), cyclin-dependent kinase 12 (CDK12), or cyclin-dependent kinase 13 (CDK13)), and therefore, induce cellular apoptosis and/or inhibit transcription in the subject.

  本发明提供了一种新型化合物的公式（I），以及其药用可接受的盐、溶剂合物、水合物、多晶形态、共晶体、互变异构体、立体异构体、同位素标记衍生物、前药和其组合物。还提供了涉及创新化合物或组合物的方法和试剂盒，用于治疗或预防增殖性疾病（例如，癌症（例如，白血病、淋巴瘤、黑色素瘤、多发性骨髓瘤、乳腺癌、尤因氏肉瘤、骨肉瘤、脑癌、神经母细胞瘤、肺癌）、良性肿瘤、血管生成、炎症性疾病、自身炎症性疾病和自身免疫疾病）的方法和试剂盒。使用本发明的化合物或组合物治疗患有增殖性疾病的对象可能抑制激酶的异常活性，如细胞周期依赖性激酶（CDK）（例如，细胞周期依赖性激酶7（CDK7）、细胞周期依赖性激酶12（CDK12）或细胞周期依赖性激酶13（CDK13）），从而在对象中诱导细胞凋亡和/或抑制转录。